Open-Label Placebo for Functional Dyspepsia
Early Phase 1
Terminated
- Conditions
- Dyspepsia
- Interventions
- Drug: Placebos
- Registration Number
- NCT03745781
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Brief Summary
The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
- Functional Dyspepsia
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description open-label placebo Placebos open-label placebo
- Primary Outcome Measures
Name Time Method dyspepsia severity on a VAS from 0-100 3 weeks How severe have your dyspepsia symptoms been over the past 7 days (on a VAS from 0-100)?
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beth Israel Deaconess Medical Center
🇺🇸Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center🇺🇸Boston, Massachusetts, United States